Paper101223
Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.
Jackson G and 4 others. Br Heart J, 1978. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol. Papers, record 101223. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/101223
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angina Pectoris | Major topic |
| Atenolol | Major topic |
| Propanolamines | Major topic |
| Propranolol | Major topic |
| Adult | |
| Blood Pressure | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Drug Administration Schedule | |
| Exercise Test | |
| Female | |
| Heart Rate | |
| Humans | |
| Male | |
| Middle Aged | |
| Nitroglycerin | |
| Random Allocation |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20791491 | Medical ethics. | Br Med J | 1968 | https://conductscience.org/library/papers/20791491 | PubMed |
| 2 | 4224228 | Unwanted effects of propranolol. | Am J Cardiol | 1966 | https://conductscience.org/library/papers/4224228 | PubMed |
| 3 | 4214119 | Coronary artery syndromes after sudden propranolol withdrawal. | Ann Intern Med | 1974 | https://conductscience.org/library/papers/4214119 | PubMed |
| 4 | 4122148 | Withdrawal of propranolol and myocardial infarction. | Lancet | 1973 | https://conductscience.org/library/papers/4122148 | PubMed |
| 5 | 4119996 | Withdrawal of propranolol and myocardial infarction. | Lancet | 1973 | https://conductscience.org/library/papers/4119996 | PubMed |
| 6 | 4118505 | Withdrawal of propranolol and myocardial infarction. | Lancet | 1973 | https://conductscience.org/library/papers/4118505 | PubMed |
| 7 | 1097925 | Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. | N Engl J Med | 1975 | https://conductscience.org/library/papers/1097925 | PubMed |
| 8 | 928268 | The demonstration of atenolol as a beta-adrenoceptor blocking drug in man. | Postgrad Med J | 1977 | https://conductscience.org/library/papers/928268 | PubMed |
| 9 | 804952 | Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris. | Br Med J | 1975 | https://conductscience.org/library/papers/804952 | PubMed |
| 10 | 240479 | Reassessment of failed beta-blocker treatment in angina pectoris by peak-exercise heart rate measurements. | Br Med J | 1975 | https://conductscience.org/library/papers/240479 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38844580 | Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular Disorders. | Handb Exp Pharmacol | 2024 | https://conductscience.org/library/papers/38844580 | PubMed |
| 28264619 | Advancements in pharmacotherapy for angina. | Expert Opin Pharmacother | 2017 | https://conductscience.org/library/papers/28264619 | PubMed |
| 7426146 | Haemodynamic and metabolic effects of atenolol in patients with angina pectoris. | Br Heart J | 1980 | https://conductscience.org/library/papers/7426146 | PubMed |
| 7093092 | Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093092 | PubMed |
| 7075651 | Comparison of once and twice daily sotalol in exercise-induced angina pectoris. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7075651 | PubMed |
| 6749509 | Clinical pharmacokinetics of atenolol--a review. | Eur J Drug Metab Pharmacokinet | 1982 | https://conductscience.org/library/papers/6749509 | PubMed |
| 6148991 | Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6148991 | PubMed |
| 3917674 | Oral labetalol in the management of stable angina pectoris in normotensive patients. | Br Heart J | 1985 | https://conductscience.org/library/papers/3917674 | PubMed |
| 3304367 | Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate. | Br Heart J | 1987 | https://conductscience.org/library/papers/3304367 | PubMed |
| 2540054 | Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial. | Diabetologia | 1989 | https://conductscience.org/library/papers/2540054 | PubMed |
| 38096 | Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension. | Drugs | 1979 | https://conductscience.org/library/papers/38096 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/101223
GET https://conductscience.org/api/papers/v1/101223/authors